Decision letter: Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations
Samir Parekh(The Ohio State University Wexner Medical Center)
Cited by 0
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
|Cancer Cell|2021|216
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy
|Blood|2022|103
A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma
|Blood Advances|2017|60